The following is a summary of “Effect of spesolimab on sustained disease control in patients with generalized pustular ...

In 2024 the SMC accepted several other cancer drugs including dabrafenib, known by the brand name Finlee, for use in combination with trametinib (Spexotras), for treating children aged one and older ...

The Scottish Medicines Consortium has approved two new drugs for use with patients via the NHS. Two new medicines have been ...

TWO new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines ...